Dow Corning to Showcase at MD&M West Expansion in New Capabilities, High-Performance Silicones to Drive Healthcare Innovation

Dow Corning, a global leader in silicones, silicon-based technology and innovation and a wholly owned subsidiary of The Dow Chemical Company, will announce at MD&M West 2017 the expansion of its Midland-based North American Healthcare Application Center, together with the latest additions to its growing healthcare product portfolio. The company’s strategic investments in research and development are designed to help healthcare customers drive innovation by leveraging advanced silicone technologies in wearable medical devices and other critical applications.

This content was submitted directly to this website by the supplier.

Dow Corning will be exhibiting at MD&M West its extensive portfolio of industry-leading silicone adhesive solutions, elastomers and coatings in booth #1921. The company will also deliver a presentation at R.D. Abbott’s Healthcare Elastomers Luncheon on Wednesday, Feb. 8, from 11:30 a.m. to 1:00 p.m. PST. William Inman, applications engineer for Dow Corning, will present on the factors to consider for post-curing silicone elastomers.

Dow Corning's new application development capabilities were added to its North American Healthcare Application Center to better help customers design next-generation medical devices using Dow Corning silicone elastomers and adhesives. Products to be spotlighted at MD&M West include a new high-performance soft skin adhesive and a versatile, recently announced aqueous emulsion.

Dow Corning’s commercial and technical experts will be on hand for the duration of MD&M West to answer questions and discuss how the company’s expanding capabilities and product portfolio are helping to meet customer needs and healthcare industry demand for higher performing advanced materials.

MD&M West 2017 will run Feb. 7-9, at the Anaheim Convention Center, in Anaheim, Calif.

Companies in this article
More in Home